Testing lab markers that may predict chemotherapy benefit
Part of Cancer, Digestive system clinical trials.
This pilot study looks at stomach (gastric) and upper stomach/cardia cancer to find lab “markers” that could predict whether chemotherapy before and after surgery will work better. If you qualify, your tumor or blood samples may be tested to understand who benefits most from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach cancer (gastric adenocarcinoma) or cardia cancer
- You are over 18 years old
- Your overall health score is 3 or less (WHO performance status)
- You can and do sign informed consent
- You are not currently being treated with chemotherapy for another cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study looks at using a blood test that finds tiny bits of cancer DNA to decide if you need extra chemotherapy after surgery. It aims to make treatment more personalized and reduce side effects for people with locally advanced stomach cancer.
This trial uses advanced imaging (ultrasound and CT) plus a blood test to predict how well your stomach cancer will respond to chemotherapy given before surgery. The goal is to personalize your treatment and improve outcomes.
This trial is testing whether using a blood test to find tiny amounts of cancer DNA after initial treatment can guide decisions about further therapy for people with stomach cancer. The goal is to personalize follow-up treatment to reduce the chance of cancer returning.
This trial collects and studies tumor and lymph node samples from people with gastric cancer who have had chemotherapy and surgery. The goal is to understand how cancer responds to treatment and to improve future care.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
Hear when a new Gastric and Cardia Adenocarcinomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.